Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III maintenance study of ZKAB001 in osteosarcoma
CTR20192678Phase 3Active
- Sponsor
- Zhaoke Ophthalmology
- Start
- Aug 2020
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of socazolimab in osteosarcoma (OS), sponsored by Zhaoke Ophthalmology. Started Aug 2020; status: active.
02
Drugs
socazolimab
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on CTR20192678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192678.